Browne, Pamela D.
Bolte, Antoinette C.
Besseling-van der Vaart, Isolde
Claassen, Eric
de Weerth, Carolina
Funding for this research was provided by:
Clinical Research Organization Rotterdam
Winclove probiotics B.V.
Netherlands Organization for Scientific Research - VICI grant (016.Vici.185.038-to de Weerth)
Jacobs Foundation Advanced Research Fellowship (to de Weerth)
Article History
Received: 21 November 2019
Accepted: 23 December 2020
First Online: 4 February 2021
Competing interests
: Eric Claassen is a consultant for several commercial parties in the field of probiotics; none of his advising practices are in direct conflict with the content of this pilot trial. Isolde Besseling-Van der Vaart is employed at Winclove Probiotics B.V. fulfilling the function of Manager Research Partnerships. The other authors have no conflict of interest.